Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
The American Journal of Pathology
|
February 2, 2011
Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples
Mitchell J Frederick, Amy J VanMeter, Mayur A Gadhikar, et al.
Nature Medicine
|
September 26, 2018
Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia
Megan L Gill, Peter J Grahn, Jonathan S Calvert, et al.
Cancer Research
|
December 5, 2000
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma
C P Paweletz, D K Ornstein, M J Roth, et al.
The Journal of Clinical Investigation
|
April 21, 2005
Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment
Puneeth Iyengar, Virginia Espina, Terence W Williams, et al.
Mayo Clinic Proceedings
|
April 8, 2017
Enabling Task-Specific Volitional Motor Functions via Spinal Cord Neuromodulation in a Human With Paraplegia
Peter J Grahn, Igor A Lavrov, Dimitry G Sayenko, et al.
Cell Reports Methods
|
September 17, 2021
Uncovering biomarkers during therapeutic neuromodulation with PARRM: Period-based Artifact Reconstruction and Removal Method
Evan M Dastin-van Rijn, Nicole R Provenza, Jonathan S Calvert, et al.
Nature Biomedical Engineering
|
March 12, 2026
Perilesional neuromodulation replaces lost sensorimotor function in persons with spinal cord injury
Jonathan S Calvert, Samuel R Parker, Lakshmi N Govindarajan, et al.
Molecular Cancer Therapeutics
|
August 20, 2021
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria
Christopher W Schultz, Grace A McCarthy, Teena Nerwal, et al.
The American Journal of Pathology
|
February 13, 2002
Evaluation of non-formalin tissue fixation for molecular profiling studies
John W Gillespie, Carolyn J M Best, Verena E Bichsel, et al.
Plos One
|
April 7, 2021
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial
Patricia M LoRusso, Aleksandar Sekulic, Jeffrey A Sosman, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
The American Journal of Pathology
|
February 2, 2011
Phosphoproteomic analysis of signaling pathways in head and neck squamous cell carcinoma patient samples
Mitchell J Frederick, Amy J VanMeter, Mayur A Gadhikar, et al.
Nature Medicine
|
September 26, 2018
Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegia
Megan L Gill, Peter J Grahn, Jonathan S Calvert, et al.
Cancer Research
|
December 5, 2000
Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma
C P Paweletz, D K Ornstein, M J Roth, et al.
The Journal of Clinical Investigation
|
April 21, 2005
Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment
Puneeth Iyengar, Virginia Espina, Terence W Williams, et al.
Mayo Clinic Proceedings
|
April 8, 2017
Enabling Task-Specific Volitional Motor Functions via Spinal Cord Neuromodulation in a Human With Paraplegia
Peter J Grahn, Igor A Lavrov, Dimitry G Sayenko, et al.
Cell Reports Methods
|
September 17, 2021
Uncovering biomarkers during therapeutic neuromodulation with PARRM: Period-based Artifact Reconstruction and Removal Method
Evan M Dastin-van Rijn, Nicole R Provenza, Jonathan S Calvert, et al.
Nature Biomedical Engineering
|
March 12, 2026
Perilesional neuromodulation replaces lost sensorimotor function in persons with spinal cord injury
Jonathan S Calvert, Samuel R Parker, Lakshmi N Govindarajan, et al.
Molecular Cancer Therapeutics
|
August 20, 2021
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria
Christopher W Schultz, Grace A McCarthy, Teena Nerwal, et al.
The American Journal of Pathology
|
February 13, 2002
Evaluation of non-formalin tissue fixation for molecular profiling studies
John W Gillespie, Carolyn J M Best, Verena E Bichsel, et al.
Plos One
|
April 7, 2021
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial
Patricia M LoRusso, Aleksandar Sekulic, Jeffrey A Sosman, et al.
Page
of 9